What was Theranos' strategy/competitive advantage? Low prices Ability to run multiple tests using the same drop of
Fantastic news! We've Found the answer you've been seeking!
Question:
- What was Theranos' strategy/competitive advantage?
- Low prices
- Ability to run multiple tests using the same drop of blood
- Convenience
- Claimed to be able to provide fast test results, unlike other laboratories that take days or weeks
- Part of their strategy was to partner with popular companies and high value individuals to gain trust
- What were the issues/concerns raised about Theranos?
- Patients were misdiagnosed
- Fraudulent claims
- Fake test reports
- Secrecy and lies - wouldn't tell the public how the product works causing speculation about if the results are accurate
- There leadership - Theranos was designed by a Stanford dropout without medical experience or training
- Theranos' high valuation of billions of dollars led to speculation in the public
- Scientists were sceptical due to the fact that Theranos chose not to present their product at professional meetings and share live demonstrations and data.
- It was taking a drastically long time for the FDA's approval
- How did Theranos garner a valuation of $6 billion?
Research Theranos today to answer the follow question
- What are your views on what really happened at Theranos and whether this constituted fraud?
Read the Financial Statements case study and answer the following questions
- Identify how Disney makes money, i.e. where it earns its revenue?
- Calculate each business segment's contribution to Disney's total revenue and operating income? Provide data in chart format.
- What is the primary driver of revenue for each of Disney's segments?
Related Book For
International Marketing And Export Management
ISBN: 9781292016924
8th Edition
Authors: Gerald Albaum , Alexander Josiassen , Edwin Duerr
Posted Date: